메뉴 건너뛰기




Volumn 33, Issue 8, 2013, Pages 812-816

Emergent renal dysfunction with colistin pharmacotherapy

Author keywords

Acinetobacter; Colistin; Gram negative; Multidrug resistant; Polymyxin

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE; AMPHOTERICIN B; COLISTIN; CONTRAST MEDIUM; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TACROLIMUS;

EID: 84885219865     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1271     Document Type: Review
Times cited : (28)

References (21)
  • 1
    • 78449246200 scopus 로고    scopus 로고
    • Current epidemiology of multidrugresistant gram-negative bacilli in the United States
    • Kallen AJ, Srinivasan A. Current epidemiology of multidrugresistant gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 2010;31(Suppl. 1):S51-4.
    • (2010) Infect Control Hosp Epidemiol , vol.31 , Issue.SUPPL. 1
    • Kallen, A.J.1    Srinivasan, A.2
  • 2
    • 17644389620 scopus 로고    scopus 로고
    • Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
    • Falagas ME, Kasiakou SK, Saravolatz LD. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40:1333-41.
    • (2005) Clin Infect Dis , vol.40 , pp. 1333-1341
    • Falagas, M.E.1    Kasiakou, S.K.2    Saravolatz, L.D.3
  • 4
    • 72449141579 scopus 로고    scopus 로고
    • Colistin therapy for microbiologically documented multidrug-resistant gram-negative bacterial infections: A retrospective cohort study of 258 patients
    • Falagas ME, Rafailidis PI, Ioannidou E, et al. Colistin therapy for microbiologically documented multidrug-resistant gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents 2010;35:194-9.
    • (2010) Int J Antimicrob Agents , vol.35 , pp. 194-199
    • Falagas, M.E.1    Rafailidis, P.I.2    Ioannidou, E.3
  • 5
    • 66949152183 scopus 로고    scopus 로고
    • Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center
    • Hartzell JD, Neff R, Ake J, et al. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin Infect Dis 2009;48:1724-8.
    • (2009) Clin Infect Dis , vol.48 , pp. 1724-1728
    • Hartzell, J.D.1    Neff, R.2    Ake, J.3
  • 6
    • 70249118469 scopus 로고    scopus 로고
    • Clinical characteristics and risk factors of colistin-induced nephrotoxicity
    • Kim J, Lee K-H, Yoo S, Pai H. Clinical characteristics and risk factors of colistin-induced nephrotoxicity. Int J Antimicrob Agents 2009;34:434-8.
    • (2009) Int J Antimicrob Agents , vol.34 , pp. 434-438
    • Kim, J.1    Lee, K.-H.2    Yoo, S.3    Pai, H.4
  • 7
    • 77949657395 scopus 로고    scopus 로고
    • Predictors of acute kidney injury associated with intravenous colistin treatment
    • Kwon JA, Lee JE, Huh W, et al. Predictors of acute kidney injury associated with intravenous colistin treatment. Int J Antimicrob Agents 2010;35:473-7.
    • (2010) Int J Antimicrob Agents , vol.35 , pp. 473-477
    • Kwon, J.A.1    Lee, J.E.2    Huh, W.3
  • 8
    • 10244236377 scopus 로고    scopus 로고
    • Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
    • Acute Dialysis Quality Initiative
    • Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12.
    • (2004) Crit Care , vol.8
    • Bellomo, R.1    Ronco, C.2    Kellum, J.A.3    Mehta, R.L.4    Palevsky, P.5
  • 9
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
    • (1976) Nephron , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 10
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
    • (1987) J Chronic Dis , vol.40 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.L.3    Mackenzie, C.R.4
  • 12
    • 84885238148 scopus 로고    scopus 로고
    • Acute kidney injury
    • Tisdale JE, Miller DA, eds. 2nd ed. Bethesda, MD: American Society of Health-System Pharmacists
    • Pai AB, Mason DL. Acute kidney injury. In: Tisdale JE, Miller DA, eds. Drug-induced diseases. Prevention, detection, and management, 2nd ed. Bethesda, MD: American Society of Health-System Pharmacists, 2010:853-71.
    • (2010) Drug-induced Diseases. Prevention, Detection, and Management , pp. 853-871
    • Pai, A.B.1    Mason, D.L.2
  • 13
    • 73549097280 scopus 로고    scopus 로고
    • Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant gram-negative bacterial infections
    • Cheng CY, Sheng WH, Wang JT, Chen YC, Chang SC. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant gram-negative bacterial infections. Int J Antimicrob Agents 2010;35:297-300.
    • (2010) Int J Antimicrob Agents , vol.35 , pp. 297-300
    • Cheng, C.Y.1    Sheng, W.H.2    Wang, J.T.3    Chen, Y.C.4    Chang, S.C.5
  • 14
    • 77953705195 scopus 로고    scopus 로고
    • Effectiveness and safety of colistin: Prospective comparative cohort study
    • Paul M, Bishara J, Levcovich A, et al. Effectiveness and safety of colistin: prospective comparative cohort study. J Antimicrob Chemother 2010;65:1019-27.
    • (2010) J Antimicrob Chemother , vol.65 , pp. 1019-1027
    • Paul, M.1    Bishara, J.2    Levcovich, A.3
  • 15
    • 80054088449 scopus 로고    scopus 로고
    • Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system
    • Pogue JM, Lee J, Marchaim D, et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis 2011;53:879-84.
    • (2011) Clin Infect Dis , vol.53 , pp. 879-884
    • Pogue, J.M.1    Lee, J.2    Marchaim, D.3
  • 16
    • 84860176935 scopus 로고    scopus 로고
    • Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients
    • Gauthier TP, Wolowich WR, Reddy A, Cano E, Abbo L, Smith LB. Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients. Antimicrob Agents Chemother 2012;56:2392-6.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 2392-2396
    • Gauthier, T.P.1    Wolowich, W.R.2    Reddy, A.3    Cano, E.4    Abbo, L.5    Smith, L.B.6
  • 17
    • 79959248672 scopus 로고    scopus 로고
    • Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients
    • Garonzik SM, Li J, Thamlikitkul V, et al. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother 2011;55:3284-94.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 3284-3294
    • Garonzik, S.M.1    Li, J.2    Thamlikitkul, V.3
  • 18
    • 42049113605 scopus 로고    scopus 로고
    • Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity
    • Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother 2008;52:1330-6.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 1330-1336
    • Lodise, T.P.1    Lomaestro, B.2    Graves, J.3    Drusano, G.L.4
  • 19
    • 67651113645 scopus 로고    scopus 로고
    • Relationship between initial vancomycin concentrationtime profile and nephrotoxicity among hospitalized patients
    • Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentrationtime profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009;49:507-14.
    • (2009) Clin Infect Dis , vol.49 , pp. 507-514
    • Lodise, T.P.1    Patel, N.2    Lomaestro, B.M.3    Rodvold, K.A.4    Drusano, G.L.5
  • 20
    • 62449183879 scopus 로고    scopus 로고
    • Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
    • Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009;66:82-98.
    • (2009) Am J Health Syst Pharm , vol.66 , pp. 82-98
    • Rybak, M.1    Lomaestro, B.2    Rotschafer, J.C.3
  • 21
    • 81555200425 scopus 로고    scopus 로고
    • Relationship between vancomycin trough concentrations and nephrotoxicity: A prospective multicenter trial
    • Bosso JA, Nappi J, Rudisill C, et al. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother 2011;55:5475-9.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 5475-5479
    • Bosso, J.A.1    Nappi, J.2    Rudisill, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.